Antitrust concerns and the FDA approval process :  hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fifteenth Congress, first session, July 27, 2017. 
 Antitrust concerns and the Food and Drug Administration approval process 

 - iv, 51 pages ;  24 cm 
<br/><br/> Shipping list no.: 2018-0202-M.  "Serial no. 115-27."  CRDP Program record. 
<br/><br/><br/>Microfiche. <br/>[Washington, D.C.] : <br/>U.S. Government Printing Office, <br/>[2018] <br/>1 microfiche : negative. 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration --Rules and practice.<br/>United States. Food and Drug Administration. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Drugs--Testing.--United States<br/>Drug approval--United States.<br/>Drugs--Safety regulations--United States.<br/>Medical instruments and apparatus--Safety regulations--United States.<br/>Generic drugs--United States.<br/>Competition--United States.<br/>Antitrust law--United States.<br/>Antitrust law.<br/>Competition.<br/>Drug approval.<br/>Drugs--Safety regulations.<br/>Drugs--Testing.<br/>Generic drugs.<br/>Medical instruments and apparatus--Safety regulations.
<br/><br/><label>Subjects--Geographic Terms: </label><br/>United States.
<br/><br/><label>Index Terms--Genre/Form: </label><br/>Legislative hearings.<br/>Legislative hearings.<br/>Rules.
<br/><br/><label>LC Class. No.: </label>KF27  / .J874 2017h 
<br/><br/><label>GPO Item No.: </label>1020-B (MF) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.J 89/1:115-27 
<br/><br/><label>Report. No.: </label>Serial no. 115-27 (United States. Congress. House. Committee on the Judiciary)